Molecular modeling of novel potent agents for treating Alzheimer's disease

Molecular modeling of novel potent agents for treating Alzheimer's disease
Specific interactions between amyloid precursor protein (APP) and curcumin indicate that curcumin protects the APP attack site (Ala19) of APP from the γ-secretase. Credit: (c) 2015 Toyohashi University Of Technology

Alzheimer's disease (AD), a severe form of dementia among aged individuals, is caused by accumulation of amyloid-beta (Aβ) peptides in the brain. Numerous types of agents have been developed to suppress the production of Aβ, by inhibiting the secretase-mediated cleavage of amyloid precursor protein (APP) into Aβ peptides.

However, because the secretases also play important roles in the production of vital proteins for the human body, inhibitors of the secretases have increased risk for side effects.

Currently, Toyohashi Tech researchers in cooperation with a researcher at the National Academy of Sciences in Ukraine, proposed new agents for protecting the cleavage site of APP from attack by γ-secretase, based on results evaluated by their state-of-the-art molecular simulations.

They investigated the specific interactions between a short APP peptide and curcumin derivatives for the first time worldwide, using protein-ligand docking as well as ab initio molecular simulations. Curcumin is a constituent of turmeric, which is a popular yellow spice in Indian cuisine. The simulated results elucidated the specific curcumin derivative and showed that it bound more strongly to APP and inhibited the binding of secretase to APP more than the other derivatives did . Moreover, some novel curcumin derivatives were proposed as potent inhibitors of Aβ peptide production. These derivatives are novel agents for suppressing AD and are proposed based on the novel concept of preventing APP cleavage. However, this does not imply that the consumption of Indian cuisine suppresses AD.

The first author, graduate student Hiromi Ishimura said, "We have also been studying the aggregation mechanism of Aβ peptides by using molecular dynamics simulations (Okamoto et al. Journal of Molecular Graphics and Modeling, 50, 113-124, 2014; Yano et al. Chemical Physics Letters, 595-596, 242-249, 2014). By combining the present ab initio molecular simulation and the , we will be able to elucidate the mechanism and propose potent inhibitors for suppressing the aggregation of Aβ peptides. These inhibitors are used as a therapeutic agent for ADs."

Molecular modeling of novel potent agents for treating Alzheimer's disease
Graduate students Hiromi Ishimura (front side) and Ryushi Kadoya (back side) are pictured. Credit: (c) 2015 Toyohashi University Of Technology

Associate Professor Noriyuki Kurita said, "Our present molecular simulations elucidated that curcumin can bind APP and inhibit the cleavage of APP by secretase. Curcumin is a natural product contained in the root of Curcumae Rhizoma. In the laboratory of our collaborator at National Academy of Sciences in Ukraine, our proposed curcumin derivatives will be synthesized and theirs effects on experimental animals with ADs will be investigated."

Our developed state-of-the-art molecular simulations can be applied to the study of other vital proteins that play important roles in the pathogenesis of numerous diseases. In developing countries such as Ukraine, tuberculosis (TB), which is a severe infection caused by Mycobacterium tuberculosis is prevalent. In fact, about 9 million people are infected with TB worldwide and 1.5 million died from this infection in 2013. Therefore, the urgent development of novel drugs for TB is necessary. We are currently performing molecular simulations to propose novel of a protein that reduces the blood level of anti-tubercular as well as anti-human immunodeficiency virus (HIV) agents. This collaborative study with Ukrainian researchers will be applied to the "Science and Technology Research Partnership for Sustainable Development Project" organized by Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA) in 2015.


Explore further

Is the amyloid hypothesis the right path to find a treatment for Alzheimer's disease?

More information: Specific interactions between amyloid-β peptide and curcumin derivatives: ab initio molecular simulations, DOI: 10.1016/j.cplett.2015.05.023
Citation: Molecular modeling of novel potent agents for treating Alzheimer's disease (2015, June 11) retrieved 18 October 2019 from https://medicalxpress.com/news/2015-06-molecular-potent-agents-alzheimer-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
117 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more